dc.contributor
Institut Català de la Salut
dc.contributor
Grup de Recerca de Càncer i Malalties Hematològiques Infantils, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Perez-Garcia, Maria J
dc.contributor.author
Segura, Miguel F.
dc.date.accessioned
2025-10-25T08:54:39Z
dc.date.available
2025-10-25T08:54:39Z
dc.date.issued
2024-01-15T08:45:48Z
dc.date.issued
2024-01-15T08:45:48Z
dc.date.issued
2023-11-28
dc.identifier
Pérez-García MJ, Segura MF. Maintaining excellent outcomes: the impact of age cutoff reclassification on reduced therapy for neuroblastoma patients. Transl Pediatr. 2023 Nov 28;12(11):1926–30.
dc.identifier
https://hdl.handle.net/11351/10855
dc.identifier
10.21037/tp-23-391
dc.identifier
001110917200001
dc.identifier.uri
http://hdl.handle.net/11351/10855
dc.description.abstract
Survival; Neuroblastoma; Risk stratification
dc.description.abstract
Supervivència; Neuroblastoma; Estratificació del risc
dc.description.abstract
Supervivencia; Neuroblastoma; Estratificación del riesgo
dc.description.abstract
This work was funded by Instituto de Salud Carlos III through the projects “PI20/000530”, “ICI21000/76” (Co-funded by the European Regional Development Fund/European Social Fund; “A way to make Europe”/“Investing in your future”).
dc.format
application/pdf
dc.publisher
AME Publishing Company
dc.relation
Translational Pediatrics;12(11)
dc.relation
https://doi.org/10.21037/tp-23-391
dc.relation
info:eu-repo/grantAgreement/ES/PE2017-2020/PI20%2F000530
dc.rights
Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Neuroblastoma - Tractament
dc.subject
DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Germ Cell and Embryonal::Neuroectodermal Tumors::Neoplasms, Neuroepithelial::Neuroectodermal Tumors, Primitive::Neuroectodermal Tumors, Primitive, Peripheral::Neuroblastoma
dc.subject
Other subheadings::Other subheadings::/therapy
dc.subject
NAMED GROUPS::Persons::Age Groups::Child
dc.subject
ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias de células germinales y embrionarias::tumores neuroectodérmicos::neoplasias neuroepiteliales::tumores neuroectodérmicos primitivos::tumores neuroectodérmicos primitivos periféricos::neuroblastoma
dc.subject
Otros calificadores::Otros calificadores::/terapia
dc.subject
DENOMINACIONES DE GRUPOS::personas::Grupos de Edad::niño
dc.title
Maintaining excellent outcomes: the impact of age cutoff reclassification on reduced therapy for neuroblastoma patients
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
